Clinical Trials

NCT03660826 | ACTIVE_NOT_RECRUITING | PHASE2
288 participants

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2018-09-27
Completion:
2024-12-06
Conditions
  • Endometrial Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Endometrioid Adenocarcinoma
  • Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT03632239 | ENROLLING_BY_INVITATION
1000 participants

Reverse Phenotyping Core

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2020-01-23
Completion:
2028-06-01
Conditions
  • Harboring of Unexpected Genetic Variant
No Results Yet
NCT03604991 | SUSPENDED | PHASE2/PHASE3
278 participants

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2019-05-03
Completion:
2026-12-31
Conditions
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Esophageal Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT03538639 | RECRUITING
1000 participants

Vascular Disease Discovery Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2018-07-30
Completion:
2027-11-30
Conditions
  • Vascular Dysfunction
  • Genetic Mutations
  • Genetic Predisposition
No Results Yet
NCT03412877 | RECRUITING | PHASE2
285 participants

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2018-09-06
Completion:
2028-03-23
Conditions
  • Endocrine Tumors
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Gastrointestinal/Genitourinary Cancers
  • Neuroendocrine Tumors
  • Multiple Myeloma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03409432 | COMPLETED | PHASE2
26 participants

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2018-03-16
Completion:
2025-07-16
Conditions
  • Lymphomatoid Papulosis
  • Primary Cutaneous Anaplastic Large Cell Lymphoma
  • Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Recurrent T-Cell Non-Hodgkin Lymphoma
  • Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Interventions
  • DRUG
  • OTHER
NCT03326804 | ACTIVE_NOT_RECRUITING
250 participants

H1 Hip Resurfacing Arthroplasty

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2017-09-26
Completion:
2032-03-17
Conditions
  • Hip Osteoarthritis
  • Hip Necrosis
  • Hip Dysplasia
Interventions
  • DEVICE
No Results Yet
NCT03251989 | COMPLETED
326 participants

Rare CNS Tumors Outcomes &Risk

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2017-08-21
Completion:
2025-05-06
Conditions
  • High Grade Meningioma
  • Ependymoma
  • Medulloblastoma
  • PNET
  • Primary CNS Sarcoma
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page